Bond.az White LogoBond.az Black Logo

Evercore ISI Raises HP Enterprise Target on H3C Sale

Evercore ISI raised HP Enterprise price target to $40 after H3C stake sale for $986.8 million. HPE stock near 52-week high.

Isabella Martinez
ByIsabella Martinez- Senior Editor
|
0

Evercore ISI raised its price target on HP Enterprise stock (NYSE:HPE) to $40 from $30, maintaining an Outperform rating.

The stock trades at $33.62, near its 52-week high. HPE has delivered an 84% return over the past year. Market cap stands at $44.6 billion.

HP Enterprise closed the partial sale of its H3C stake for $986.8 million. The remaining 5.2% stake is expected to sell to Unisplendour in H1 2026.

More News
Today / 18:30
|
683

Morgan Stanley hikes Sunnova stock price target

Morgan Stanley increased Sunnova price target to $494 with a 36x multiple, citing strong execution and growth prospects.

0
Today / 16:32
|
824

Guggenheim Raises StubHub Target on Strong Q1

Guggenheim lifted StubHub's price target after strong Q1 results, citing revenue and EBITDA beats.

0
Today / 13:34
|
741

Jefferies Reiterates Buy on Biogen Stock

Jefferies reiterates Buy rating on Biogen stock with $210 target following promising Phase II Alzheimer's data.

0
Today / 13:32
|
873

Marvell price target raised to $200 by RBC on optical strength

RBC Capital raised Marvell Technology price target to $200, citing optical business strength. AI networking and custom XPU trends support growth.

0
Today / 13:03
|
769

Morgan Stanley Upgrades Assurant Stock Rating

Morgan Stanley upgrades Assurant stock to Overweight, raises price target to $285. Strong earnings and growth outlook highlighted.

0
Today / 12:41
|
890

Biogen Stock Rises as Stifel Maintains Buy

Biogen stock rises as Stifel maintains buy rating. Updates on Alzheimer's drug trial and financial results.

0
Today / 12:32
|
422

Compass Point raises Nebius target to $260 on strong Q1

Compass Point raised Nebius price target to $260 on strong Q1 results. ARR and AI Cloud revenue surge. Read more on Bond.az.

0
Today / 11:44
|
476

H.C. Wainwright Reiterates Immunic Stock Rating

H.C. Wainwright maintains Buy rating and $22 price target on Immunic stock. The company awaits pivotal MS drug trial results. Read more on Bond.az.

0
Today / 11:43
|
800

H.C. Wainwright Reiterates Kamada Buy Rating

H.C. Wainwright reaffirms Buy rating on Kamada with $13 target. Kamada expects double-digit revenue growth in 2026.

0
Today / 11:42
|
902

Titan Mining Price Target Cut by H.C. Wainwright

H.C. Wainwright cuts Titan Mining price target to $6.50, maintains Buy. Stock up 357% in a year, but Bond.az flags overvaluation risk.

0
Today / 11:41
|
334

Avino Silver & Gold Target Raised by Analyst

H.C. Wainwright raises Avino Silver & Gold price target to $13.00 after strong earnings report with 109% revenue growth.

0
Today / 11:05
|
280

Truist reiterates Buy on Uber stock

Truist Securities reiterates Buy on Uber stock with $112 target, citing AV strength and growth potential.

0
...